Compounds and methods of promoting myelination
First Claim
Patent Images
1. A method of treating a subject with primary progressive multiple sclerosis, comprising administering an effective amount of Cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop-2-enylamine or a pharmaceutically acceptable salt thereof to the subject.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention is a method of treating a subject with primary progressive or secondary progressive multiple sclerosis. The method comprises administering an effect amount of Cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop-2-enylamine or a pharmaceutically acceptable salt thereof to the subject.
9 Citations
2 Claims
-
1. A method of treating a subject with primary progressive multiple sclerosis, comprising administering an effective amount of Cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop-2-enylamine or a pharmaceutically acceptable salt thereof to the subject.
-
2. A method of treating a subject with secondary progressive multiple sclerosis, comprising administering an effective amount of Cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop-2-enylamine or a pharmaceutically acceptable salt thereof to the subject.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeCase Western Reserve University
-
Original AssigneeCase Western Reserve University
-
InventorsTesar, Paul, Adams, Drew, Landau, Steven B.
-
Primary Examiner(s)Ricci, Craig D
-
Assistant Examiner(s)Coppins, Janet L.
-
Application NumberUS16/229,875Publication NumberTime in Patent Office788 DaysField of Search514646US Class CurrentCPC Class CodesA61K 31/135 having aromatic rings , e.g...A61K 31/137 Arylalkylamines, e.g. amphe...A61P 25/28 for treating neurodegenerat...
